Prostate Cancer - Results from #780

The cost effectiveness of MRI-driven prostate cancer detection, "Beyond the Abstract," by Maarten de Rooij June 5, 2014

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development, "Beyond the Abstract," by Dong Lin, Alexander W. Wyatt, Colin C. Collins, and Yuzhuo Wang June 5, 2014

Full field optical coherence tomography (FFOCT) of prostate biopsies: A step towards pre-histological diagnosis? "Beyond the Abstract," by Nicolas Barry Delongchamps, MD May 30, 2014

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo, "Beyond the Abstract," by Somanath P.R. Shenoy, PhD, FAHA May 30, 2014

A population-based observational study of practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy, "Beyond the Abstract," by Aaron C. Weinberg, MD May 30, 2014

Prognostic value of discs large homolog 7 transcript levels in prostate cancer, "Beyond the Abstract," by George Vasmatzis, PhD and Christian Gomez, PhD May 16, 2014

Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer, "Beyond the Abstract," by Sam Beddar, PhD, DABR, FCCPM, FAAPM May 16, 2014

Key considerations for the experimental training and evaluation of cancer odour detection dogs, "Beyond the Abstract," by Hywel C. Williams, DSc, FRCP, et al May 15, 2014

Can single positive core prostate cancer at biopsy be considered a low-risk disease after radical prostatectomy? "Beyond the Abstract," by Ricardo Kupka, MD May 9, 2014

Early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone: A randomized controlled trial following robot-assisted laparoscopic radical prostatectomy, "Beyond the Abstract," by Sandip M. Prasad, MD May 8, 2014

PSA screening, lives saved, and hormonal monotherapy: It’s time to face some quietly ignored facts, "Beyond the Abstract," by Ian Haines, MBBS, FRACP, FAChPM and George L. Gabor Miklos, PhD May 6, 2014

Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells, "Beyond the Abstract," by Sanjay Gupta April 29, 2014

A possible link between bilateral orchiectomy for metastatic prostate cancer treatment and high cardiovascular risk, "Beyond the Abstract," by Konstantinos Stamatiou April 28, 2014

The pitfall of the small cell prostate carcinoma variant resulting in a false-negative bone scan and choline PET/CT study in a case of prostate cancer, "Beyond the Abstract," by Ammad Al Tamimi MD, FRCR April 25, 2014

In clinical practice, a higher cancer detection rate is possible utilizing 3D versus 2D systematic transrectal ultrasound-guided prostate biopsy, "Beyond the Abstract," by Aoun Fouad, MD April 24, 2014

A critical review of enzalutamide in the treatment of metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Ashley Freeman, MD and Jeanny B. Aragon-Ching, MD April 22, 2014

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Cora. N. Sternberg and Peter Mulders April 21, 2014

Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue, "Beyond the Abstract," by Fernando Korkes, MD, PhD, et al April 17, 2014

Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors, "Beyond the Abstract," by Michel D. Wissing, Madeleine S.Q. Kortenhorst, and Luigi Marchionni April 17, 2014

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells, "Beyond the Abstract," by Carlos Perez-Stable, PhD April 11, 2014

Page 40 of 58